SOURCE: Industrial Info Resources

Industrial Info Resources

May 24, 2010 05:10 ET

Another Big Wedding for Pharma: Astellas Invests $4 Billion in OSI Pharmaceuticals Dowry, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - May 24, 2010) -  Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Spring is in the air and the Pharmaceutical-Biotech Industry is celebrating its first major marriage of the season -- that is, a merger and acquisition, for those less metaphorically inclined. After a rocky courtship lasting several months, one filled with possible threats and rival suitors, Japan's Astellas Pharmaceuticals Incorporated (TYO: 4503) (Tokyo) found $4 billion to be the magic number to win OSI Pharmaceuticals (NASDAQ:OSIP) (Melville, New York).

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=160732, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. IIR's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

Follow us on: Facebook - Twitter - LinkedIn - Vimeo

Contact Information

  • Contact:
    Joe Govreau
    713-783-5147